Global CAR-T Cell Therapy Market (By Indication (Diffuse Large B-Cell Lymphoma, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia and Others), By Target Antigen (BCMA (B-Cell Maturation Antigen), CD19/CD22 and Others)) – Prospective Landscape, Size, Share, Growth, Opportunities and Industry Forecast 2019-2028

Published DateReport CodeNo. of PagesReport Format
July – 2020AMR-9029110PDF / Excel

” Global CAR-T Cell Therapy market is projected to reach at US$ 5001.72 million by 2028 “

SelectLicense Type

Market Insight

CAR-T Cell Therapy is a revolutionary cancer therapy that can help to represent the paradigm shift in effective cancer treatments. Favorable government initiatives, rising prevalence of healthcare infrastructure and extensive research and development in cell therapy in cancer are prominent factors propelling the global market growth over the forecast timeframe. Favorable initiatives from the Food and Drug Administration, research, and developments from Cancer Research Institutes are fueling the global market over the forthcoming years. Increasing incidence of cancer across the global regions is fueling the revolutionary cancer therapies at the global level.

However, different side effects associated with cell therapy that lead to neurological problems and cytokine release syndrome is hindering the global market growth opportunities in the global CAR-T Cell Therapy Market. The notable approvals from Kymriah and Yescarta in 2017 have encouraged the advancements in the global market. This emerging treatment is one of the promising treatments for cancer patients where doctors collect immune cells from patients and modify them with the help of treatment and infuse them into the patient’s body. Furthermore, development of new and effective therapy alternatives to cure symptoms of the diseases is also primary factor propelling the global market demand. Different National Cancer Advisory Board has started with initiatives to accelerate research in cancer therapies with the help of CAR-T cell therapy.

The global market research report on, “CAR-T Cell Therapy Market” boons an in-depth synopsis of the competitive, regional, and business framework of the global market thus helping established enterprises and new entrants to understand the in-depth global market insights, that can formulate the strategic business decisions in businesses. The global CAR-T Cell Therapy market size was estimated at USD 391.99 million in 2019 and is relied upon to enlist a CAGR 32.7 % over the estimated time frame 2019-2028.

The geographical outlook of the global CAR T Cell Therapy Market has been scrutinized through proven research methodologies such as qualitative and quantitative analysis that sheds light on subjective data of the market. Different informative insights have been collected through different data exploratory techniques such as primary and secondary research by using various reliable sources such as press releases and websites, industry presentations, industrial reports, and different databases. Market research is an essential part of any business development process, for making well-informed strategic decisions for sustainable development of the global market.

Regional Insights

  • Across the global regions, North America is the dominant market in the CAR-T Cell Therapy Market owing to development and launches of effective therapies for the treatment of cancer. Different leading key companies operating across North America attributed to the markable growth in the global market.
  • Heavy investments and extensive research for the development of cancer treatment therapies are anticipated to make significant growth across Europe. Effective research and global collaborations of the leading manufacturers across the Asia-Pacific region is also propelling the global market growth. Increasing occurrence of cancer cases is also boosting global market growth opportunities.

Key Industry Developments

  • Presently, two leading manufacturers such as Novartis AG and Gilead Sciences, Inc have initiated the commercializing different effective products in global CAR-T cell therapy and those products are streamlining for approval.
  • In Feb 2018 Gilead Sciences Inc collaborated with Sangamo Therapeutics Inc with the help of gene-editing technology for the effective development of cancer treatment.

List of Companies profiled in the report

For an effective understanding of the competitive landscape in global CAR-T Cell Therapy, market different leading key players have been profiled with the help of proven research methodologies like primary and secondary research. It offers meticulous data based on different attributes such as company overview, market size, market shares, recent trends, and business strategies carried out by leading key players. These leading key companies across the global market have broadened their customer base across the global market by focusing on some significant aspects of the global market such as product launches, innovations, partnerships, and collaborations. Furthermore, the granular view of the global market dynamics is also elucidated in this report.

Following key players have been profiled in the report

  • Novartis International AG
  • Kite Pharma, Inc
  • Juno Therapeutics
  • Bluebird Bio, Inc
  • Mustang Bio, Inc
  • Sorrento Therapeutics Inc
  • Aurora Biopharma Inc
  • Legend Biotech
  • Pfizer
  • CARsgen Therapeutics, Ltd

Report Scope by Market Segments

The global CAR-T Cell Therapy Market has fragmented into different global market segments based on various perspectives such as Indication type, target antigen, and global geographies across the world.

CAR-T Cell Therapy Market Segmentation

Indication Perspective (Revenue in USD Million)

  • Diffuse Large B-Cell Lymphoma
  • Acute Lymphoblastic Leukemia
  • Follicular Lymphoma
  • Multiple Myeloma
  • Chronic Lymphocytic Leukemia
  • Others

Target Antigen Perspectives (Revenue in USD Million)

  • BCMA (B-Cell Maturation Antigen)
  • CD19/CD22
  • Others

Regional Perspective: (Revenue in USD Million)

  • North America
    • U.S.A
    • Canada
  • Europe
    • Italy
    • Germany
    • France
    • UK
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa

This report answers key questions such as

  • What are CAR-T Cells?
  • What will be the global market size and market shares over the forecast timeframe?
  • What are the different indications for CAR-T cell therapies?
  • Which clinical trials are conducted by global companies?
  • What are the global leading key players functioning across the global CAR-T Cell Therapy Market?
  • Which applications of the global CAR-T cell Therapy Market are generating the highest revenue over the forecast period?
  • What are the global threats, risks and challenges in front of the global market?
  • What is the timeline for the implementation of CAR-T cell therapy?
  • What is the current market status and historical developments in the global market?
  • What is the structure of a CAR-T cell in market?
  • What is the economic impact of Covid-19 on global market over the coming years?
  • What is the funding landscape in the CAR-T cell therapy market?
  • What are the future projections of CAR-T cell therapy with the arrival of new models and trends in the market?
  • Which clinical trials are carried out by global biotech companies?
  • What are the drivers, restraints, and opportunities in front of the global market?
  • What are the strengths and weaknesses of the CAR-T cell therapy industry?
  • What are the upcoming projections of global market such as market capacity, production, and productivity?
  • What is the global market for CAR-T cells by global geographies?

A new informative report on the global CAR-T Cell Therapy Market has recently published by Alchemy Market Research to its massive database for shaping the future of global businesses. This informative data has been collected through different data exploratory techniques such as primary and secondary research by using different reliable sources such as press releases and websites, presentations of industrial associations. Market research is an essential part of any business process, for making well-informed decisions in the businesses as well as to formulate strategic planning of the businesses. The notable feature of this global research report is, it comes with COVID-19 impact on different aspects of the global market.

Moreover, this analytical repository offers fully-fledged market analysis with respect to different economical aspects of the global market. This global market intelligence report offers a detailed elaboration on the regional and competitive landscape of the global market. The report is presented with industrial insights and aims to provide a strong strategic plan for the sustainable development of the global market over the upcoming years. Collectively, this informative investigation research report presents the development of the present market along with the historical developments and future projections.

The global market research report on, “CAR-T Cell Therapy Market” boons an in-depth synopsis of the competitive, regional, and business framework of the global market thus helping established enterprises and new entrants to understand the in-depth global market insights, that can formulate the strategic business decisions in businesses.

Chapter 1. Executive Summary

Chapter 2. Market Introduction

Chapter 3. Global CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028 – Key Industry Dynamics

3.1. Key Market Drivers
3.2. Key Market Restraints
3.3. Market Opportunities
3.4. Future Trends
3.5. Impact Analysis of Drivers and Restraints

Chapter 4. Global CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028

Chapter 5. Global CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028 – By Indication

5.1. Diffuse Large B-Cell Lymphoma
5.2. Acute Lymphoblastic Leukemia
5.3. Follicular Lymphoma
5.4. Multiple Myeloma
5.5. Chronic Lymphocytic Leukemia
5.6. Others

Chapter 6. Global CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028 – By Target Antigen

6.1. BCMA (B-Cell Maturation Antigen)
6.2. CD19/CD22
6.3. Others

Chapter 7. Global CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028 – By Region

7.1. North America
7.2. Europe
7.3. Asia-Pacific
7.4. Latin America
7.5. Middle East & Africa

Chapter 8. North America CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028

8.1. North America CAR-T Cell Therapy Market– By Indication

8.1.1. Diffuse Large B-Cell Lymphoma
8.1.2. Acute Lymphoblastic Leukemia
8.1.3. Follicular Lymphoma
8.1.4. Multiple Myeloma
8.1.5. Chronic Lymphocytic Leukemia
8.1.6. Others

8.2. North America CAR-T Cell Therapy Market– By Target Antigen

8.2.1. BCMA (B-Cell Maturation Antigen)
8.2.2. CD19/CD22
8.2.3. Others

8.3. North America CAR-T Cell Therapy Market– By Country

8.3.1. U.S.
8.3.2. Canada

Chapter 9. Europe CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028

9.1. Europe CAR-T Cell Therapy Market– By Indication

9.1.1. Diffuse Large B-Cell Lymphoma
9.1.2. Acute Lymphoblastic Leukemia
9.1.3. Follicular Lymphoma
9.1.4. Multiple Myeloma
9.1.5. Chronic Lymphocytic Leukemia
9.1.6. Others

9.2. Europe CAR-T Cell Therapy Market– By Target Antigen

9.2.1. BCMA (B-Cell Maturation Antigen)
9.2.2. CD19/CD22
9.2.3. Others

9.3. Europe CAR-T Cell Therapy Market– By Country

9.3.1. Germany
9.3.2. France
9.3.3. UK
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe

Chapter 10. Asia Pacific CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028

10.1. Asia Pacific CAR-T Cell Therapy Market– By Indication

10.1.1. Diffuse Large B-Cell Lymphoma
10.1.2. Acute Lymphoblastic Leukemia
10.1.3. Follicular Lymphoma
10.1.4. Multiple Myeloma
10.1.5. Chronic Lymphocytic Leukemia
10.1.6. Others

10.2. Asia Pacific CAR-T Cell Therapy Market– By Target Antigen

10.2.1. BCMA (B-Cell Maturation Antigen)
10.2.2. CD19/CD22
10.2.3. Others

10.3. Asia-Pacific CAR-T Cell Therapy Market– By Country

10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Rest of Asia-Pacific

Chapter 11. Latin America CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028

11.1. Latin America CAR-T Cell Therapy Market– By Indication

11.1.1. Diffuse Large B-Cell Lymphoma
11.1.2. Acute Lymphoblastic Leukemia
11.1.3. Follicular Lymphoma
11.1.4. Multiple Myeloma
11.1.5. Chronic Lymphocytic Leukemia
11.1.6. Others

11.2. Latin America CAR-T Cell Therapy Market– By Target Antigen

11.2.1. BCMA (B-Cell Maturation Antigen)
11.2.2. CD19/CD22
11.2.3. Others

11.3. Latin America CAR-T Cell Therapy Market– By Country

11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America

Chapter 12. Middle East & Africa CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028

12.1. Middle East & Africa CAR-T Cell Therapy Market– By Indication

12.1.1. Diffuse Large B-Cell Lymphoma
12.1.2. Acute Lymphoblastic Leukemia
12.1.3. Follicular Lymphoma
12.1.4. Multiple Myeloma
12.1.5. Chronic Lymphocytic Leukemia
12.1.6. Others

12.2. Middle East & Africa CAR-T Cell Therapy Market– By Target Antigen

12.2.1. BCMA (B-Cell Maturation Antigen)
12.2.2. CD19/CD22
12.2.3. Others

12.3. Middle East & Africa CAR-T Cell Therapy Market– By Country

12.3.1. UAE
12.3.2. Saudi Arabia
12.3.3. Turkey
12.3.4. Rest of Middle East & Africa

Chapter 13. Competitive Analysis

13.1.1. Competition Dashboard
13.1.2. Company Profiles

13.1.2.1. Novartis International AG
13.1.2.2. Kite Pharma, Inc
13.1.2.3. Juno Therapeutics
13.1.2.4. Bluebird Bio, Inc
13.1.2.5. Mustang Bio, Inc
13.1.2.6. Sorrento Therapeutics Inc
13.1.2.7. Aurora Biopharma Inc
13.1.2.8. Legend Biotech
13.1.2.9. Pfizer
13.1.2.10. CARsgen Therapeutics, Ltd

Report Description

Market Insight

CAR-T Cell Therapy is a revolutionary cancer therapy that can help to represent the paradigm shift in effective cancer treatments. Favorable government initiatives, rising prevalence of healthcare infrastructure and extensive research and development in cell therapy in cancer are prominent factors propelling the global market growth over the forecast timeframe. Favorable initiatives from the Food and Drug Administration, research, and developments from Cancer Research Institutes are fueling the global market over the forthcoming years. Increasing incidence of cancer across the global regions is fueling the revolutionary cancer therapies at the global level.

However, different side effects associated with cell therapy that lead to neurological problems and cytokine release syndrome is hindering the global market growth opportunities in the global CAR-T Cell Therapy Market. The notable approvals from Kymriah and Yescarta in 2017 have encouraged the advancements in the global market. This emerging treatment is one of the promising treatments for cancer patients where doctors collect immune cells from patients and modify them with the help of treatment and infuse them into the patient’s body. Furthermore, development of new and effective therapy alternatives to cure symptoms of the diseases is also primary factor propelling the global market demand. Different National Cancer Advisory Board has started with initiatives to accelerate research in cancer therapies with the help of CAR-T cell therapy.

The global market research report on, “CAR-T Cell Therapy Market” boons an in-depth synopsis of the competitive, regional, and business framework of the global market thus helping established enterprises and new entrants to understand the in-depth global market insights, that can formulate the strategic business decisions in businesses. The global CAR-T Cell Therapy market size was estimated at USD 391.99 million in 2019 and is relied upon to enlist a CAGR 32.7 % over the estimated time frame 2019-2028.

The geographical outlook of the global CAR T Cell Therapy Market has been scrutinized through proven research methodologies such as qualitative and quantitative analysis that sheds light on subjective data of the market. Different informative insights have been collected through different data exploratory techniques such as primary and secondary research by using various reliable sources such as press releases and websites, industry presentations, industrial reports, and different databases. Market research is an essential part of any business development process, for making well-informed strategic decisions for sustainable development of the global market.

Regional Insights

  • Across the global regions, North America is the dominant market in the CAR-T Cell Therapy Market owing to development and launches of effective therapies for the treatment of cancer. Different leading key companies operating across North America attributed to the markable growth in the global market.
  • Heavy investments and extensive research for the development of cancer treatment therapies are anticipated to make significant growth across Europe. Effective research and global collaborations of the leading manufacturers across the Asia-Pacific region is also propelling the global market growth. Increasing occurrence of cancer cases is also boosting global market growth opportunities.

Key Industry Developments

  • Presently, two leading manufacturers such as Novartis AG and Gilead Sciences, Inc have initiated the commercializing different effective products in global CAR-T cell therapy and those products are streamlining for approval.
  • In Feb 2018 Gilead Sciences Inc collaborated with Sangamo Therapeutics Inc with the help of gene-editing technology for the effective development of cancer treatment.

List of Companies profiled in the report

For an effective understanding of the competitive landscape in global CAR-T Cell Therapy, market different leading key players have been profiled with the help of proven research methodologies like primary and secondary research. It offers meticulous data based on different attributes such as company overview, market size, market shares, recent trends, and business strategies carried out by leading key players. These leading key companies across the global market have broadened their customer base across the global market by focusing on some significant aspects of the global market such as product launches, innovations, partnerships, and collaborations. Furthermore, the granular view of the global market dynamics is also elucidated in this report.

Following key players have been profiled in the report

  • Novartis International AG
  • Kite Pharma, Inc
  • Juno Therapeutics
  • Bluebird Bio, Inc
  • Mustang Bio, Inc
  • Sorrento Therapeutics Inc
  • Aurora Biopharma Inc
  • Legend Biotech
  • Pfizer
  • CARsgen Therapeutics, Ltd

Report Scope by Market Segments

The global CAR-T Cell Therapy Market has fragmented into different global market segments based on various perspectives such as Indication type, target antigen, and global geographies across the world.

CAR-T Cell Therapy Market Segmentation

Indication Perspective (Revenue in USD Million)

  • Diffuse Large B-Cell Lymphoma
  • Acute Lymphoblastic Leukemia
  • Follicular Lymphoma
  • Multiple Myeloma
  • Chronic Lymphocytic Leukemia
  • Others

Target Antigen Perspectives (Revenue in USD Million)

  • BCMA (B-Cell Maturation Antigen)
  • CD19/CD22
  • Others

Regional Perspective: (Revenue in USD Million)

  • North America
    • U.S.A
    • Canada
  • Europe
    • Italy
    • Germany
    • France
    • UK
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa

This report answers key questions such as

  • What are CAR-T Cells?
  • What will be the global market size and market shares over the forecast timeframe?
  • What are the different indications for CAR-T cell therapies?
  • Which clinical trials are conducted by global companies?
  • What are the global leading key players functioning across the global CAR-T Cell Therapy Market?
  • Which applications of the global CAR-T cell Therapy Market are generating the highest revenue over the forecast period?
  • What are the global threats, risks and challenges in front of the global market?
  • What is the timeline for the implementation of CAR-T cell therapy?
  • What is the current market status and historical developments in the global market?
  • What is the structure of a CAR-T cell in market?
  • What is the economic impact of Covid-19 on global market over the coming years?
  • What is the funding landscape in the CAR-T cell therapy market?
  • What are the future projections of CAR-T cell therapy with the arrival of new models and trends in the market?
  • Which clinical trials are carried out by global biotech companies?
  • What are the drivers, restraints, and opportunities in front of the global market?
  • What are the strengths and weaknesses of the CAR-T cell therapy industry?
  • What are the upcoming projections of global market such as market capacity, production, and productivity?
  • What is the global market for CAR-T cells by global geographies?
Report Synopsis

A new informative report on the global CAR-T Cell Therapy Market has recently published by Alchemy Market Research to its massive database for shaping the future of global businesses. This informative data has been collected through different data exploratory techniques such as primary and secondary research by using different reliable sources such as press releases and websites, presentations of industrial associations. Market research is an essential part of any business process, for making well-informed decisions in the businesses as well as to formulate strategic planning of the businesses. The notable feature of this global research report is, it comes with COVID-19 impact on different aspects of the global market.

Moreover, this analytical repository offers fully-fledged market analysis with respect to different economical aspects of the global market. This global market intelligence report offers a detailed elaboration on the regional and competitive landscape of the global market. The report is presented with industrial insights and aims to provide a strong strategic plan for the sustainable development of the global market over the upcoming years. Collectively, this informative investigation research report presents the development of the present market along with the historical developments and future projections.

The global market research report on, “CAR-T Cell Therapy Market” boons an in-depth synopsis of the competitive, regional, and business framework of the global market thus helping established enterprises and new entrants to understand the in-depth global market insights, that can formulate the strategic business decisions in businesses.

Table of Content

Chapter 1. Executive Summary

Chapter 2. Market Introduction

Chapter 3. Global CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028 – Key Industry Dynamics

3.1. Key Market Drivers
3.2. Key Market Restraints
3.3. Market Opportunities
3.4. Future Trends
3.5. Impact Analysis of Drivers and Restraints

Chapter 4. Global CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028

Chapter 5. Global CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028 – By Indication

5.1. Diffuse Large B-Cell Lymphoma
5.2. Acute Lymphoblastic Leukemia
5.3. Follicular Lymphoma
5.4. Multiple Myeloma
5.5. Chronic Lymphocytic Leukemia
5.6. Others

Chapter 6. Global CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028 – By Target Antigen

6.1. BCMA (B-Cell Maturation Antigen)
6.2. CD19/CD22
6.3. Others

Chapter 7. Global CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028 – By Region

7.1. North America
7.2. Europe
7.3. Asia-Pacific
7.4. Latin America
7.5. Middle East & Africa

Chapter 8. North America CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028

8.1. North America CAR-T Cell Therapy Market– By Indication

8.1.1. Diffuse Large B-Cell Lymphoma
8.1.2. Acute Lymphoblastic Leukemia
8.1.3. Follicular Lymphoma
8.1.4. Multiple Myeloma
8.1.5. Chronic Lymphocytic Leukemia
8.1.6. Others

8.2. North America CAR-T Cell Therapy Market– By Target Antigen

8.2.1. BCMA (B-Cell Maturation Antigen)
8.2.2. CD19/CD22
8.2.3. Others

8.3. North America CAR-T Cell Therapy Market– By Country

8.3.1. U.S.
8.3.2. Canada

Chapter 9. Europe CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028

9.1. Europe CAR-T Cell Therapy Market– By Indication

9.1.1. Diffuse Large B-Cell Lymphoma
9.1.2. Acute Lymphoblastic Leukemia
9.1.3. Follicular Lymphoma
9.1.4. Multiple Myeloma
9.1.5. Chronic Lymphocytic Leukemia
9.1.6. Others

9.2. Europe CAR-T Cell Therapy Market– By Target Antigen

9.2.1. BCMA (B-Cell Maturation Antigen)
9.2.2. CD19/CD22
9.2.3. Others

9.3. Europe CAR-T Cell Therapy Market– By Country

9.3.1. Germany
9.3.2. France
9.3.3. UK
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe

Chapter 10. Asia Pacific CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028

10.1. Asia Pacific CAR-T Cell Therapy Market– By Indication

10.1.1. Diffuse Large B-Cell Lymphoma
10.1.2. Acute Lymphoblastic Leukemia
10.1.3. Follicular Lymphoma
10.1.4. Multiple Myeloma
10.1.5. Chronic Lymphocytic Leukemia
10.1.6. Others

10.2. Asia Pacific CAR-T Cell Therapy Market– By Target Antigen

10.2.1. BCMA (B-Cell Maturation Antigen)
10.2.2. CD19/CD22
10.2.3. Others

10.3. Asia-Pacific CAR-T Cell Therapy Market– By Country

10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Rest of Asia-Pacific

Chapter 11. Latin America CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028

11.1. Latin America CAR-T Cell Therapy Market– By Indication

11.1.1. Diffuse Large B-Cell Lymphoma
11.1.2. Acute Lymphoblastic Leukemia
11.1.3. Follicular Lymphoma
11.1.4. Multiple Myeloma
11.1.5. Chronic Lymphocytic Leukemia
11.1.6. Others

11.2. Latin America CAR-T Cell Therapy Market– By Target Antigen

11.2.1. BCMA (B-Cell Maturation Antigen)
11.2.2. CD19/CD22
11.2.3. Others

11.3. Latin America CAR-T Cell Therapy Market– By Country

11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America

Chapter 12. Middle East & Africa CAR-T Cell Therapy Market– Analysis and Revenue Forecast 2019-2028

12.1. Middle East & Africa CAR-T Cell Therapy Market– By Indication

12.1.1. Diffuse Large B-Cell Lymphoma
12.1.2. Acute Lymphoblastic Leukemia
12.1.3. Follicular Lymphoma
12.1.4. Multiple Myeloma
12.1.5. Chronic Lymphocytic Leukemia
12.1.6. Others

12.2. Middle East & Africa CAR-T Cell Therapy Market– By Target Antigen

12.2.1. BCMA (B-Cell Maturation Antigen)
12.2.2. CD19/CD22
12.2.3. Others

12.3. Middle East & Africa CAR-T Cell Therapy Market– By Country

12.3.1. UAE
12.3.2. Saudi Arabia
12.3.3. Turkey
12.3.4. Rest of Middle East & Africa

Chapter 13. Competitive Analysis

13.1.1. Competition Dashboard
13.1.2. Company Profiles

13.1.2.1. Novartis International AG
13.1.2.2. Kite Pharma, Inc
13.1.2.3. Juno Therapeutics
13.1.2.4. Bluebird Bio, Inc
13.1.2.5. Mustang Bio, Inc
13.1.2.6. Sorrento Therapeutics Inc
13.1.2.7. Aurora Biopharma Inc
13.1.2.8. Legend Biotech
13.1.2.9. Pfizer
13.1.2.10. CARsgen Therapeutics, Ltd

Report Sample
Report Methodology
Report Customization
Consult the Analyst